alexa Therapeutic Algorithm Guided by Sequential 11C-Choline PET CT in a Patient With Metastatic Castration-Resistant Prostate Cancer.


Journal of Cancer Diagnosis

Author(s): Garcia Garzon JR, Bassa Pere, Soler Marina, Moragas Merce, Llinares Elena

Abstract Share this page

Antiandrogen therapy alone or combined with radical therapy is the first choice in diagnosis and recurrence of patients with metastatic prostate cancer. However, patients on androgen deprivation frequently show treatment resistance. In recent years, new treatments for metastatic castration-resistant prostate cancer have been developed. Clinical studies with docetaxel have shown its usefulness for first-line therapy, and different therapeutic algorithms with second-line drugs like abiraterone or cabazitaxel have also been proposed. Sequential metabolic study with PET/CT imaging with 11C-choline may be important for assessing the right moment for administration each one of the therapeutic options.

This article was published in Clinical Nuclear Medicine and referenced in Journal of Cancer Diagnosis

Relevant Expert PPTs

Relevant Speaker PPTs

Recommended Conferences

Relevant Topics

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version